ID

15805

Beskrivning

Treating Peritoneal Carcinomatosis With PIPAC; ODM derived from: https://clinicaltrials.gov/show/NCT02320448

Länk

https://clinicaltrials.gov/show/NCT02320448

Nyckelord

Versioner (1)
  1. 2016-06-14 2016-06-14 -
Uppladdad den

14 juni 2016

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Peritoneal Carcinomatosis NCT02320448

Engelsk

Eligibility Peritoneal Carcinomatosis NCT02320448

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
clinical and radiological evidence of peritoneal carcinomatosis.
Beskrivning

Carcinomatosis of peritoneal cavity

Datatyp

boolean

Alias
UMLS CUI [1]
C0346990
no indication for standard chemotherapy which prolongs overall survival for at least three months.
Beskrivning

No indication of Chemotherapy | Survival time

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0521090
UMLS CUI [1,2]
C0392920
UMLS CUI [2]
C2919552
performance status 0-2 and life expectancy of more than 3 months.
Beskrivning

performance status | Life Expectancy

Datatyp

boolean

Alias
UMLS CUI [1]
C1518965
UMLS CUI [2]
C0023671
age > 18 years.
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
written informed consent must be obtained according to the local ethics committee requirements.
Beskrivning

Informed consent

Datatyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
extraabdominal metastatic disease.
Beskrivning

Metastatic Neoplasm Abdomen outside

Datatyp

boolean

Alias
UMLS CUI [1,1]
C2939420
UMLS CUI [1,2]
C0000726
UMLS CUI [1,3]
C0205101
symptomatic small bowel obstruction (total parenteral nutrition, nasogastric tube).
Beskrivning

Small bowel obstruction Symptomatic | Parenteral Nutrition, Total | Nasogastric tube

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0235329
UMLS CUI [1,2]
C0231220
UMLS CUI [2]
C0030548
UMLS CUI [3]
C0085678
chemotherapy or surgery within the last four weeks prior to the first pipac application.
Beskrivning

Chemotherapy | Operative Surgical Procedures | Therapy, Investigational

Datatyp

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C0543467
UMLS CUI [3]
C0949266
previous treatment with maximum cumulative doses of doxorubicin, daunorubicin, epirubicin, idarubicin, and/or other anthracyclines and anthracenediones.
Beskrivning

Prior Therapy Cumulative Dose Maximum | Doxorubicin | Daunorubicin | Epirubicin | Idarubicin | Anthracyclines | Anthraquinones

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C2986497
UMLS CUI [1,3]
C0806909
UMLS CUI [2]
C0013089
UMLS CUI [3]
C0011015
UMLS CUI [4]
C0014582
UMLS CUI [5]
C0020789
UMLS CUI [6]
C0282564
UMLS CUI [7]
C0003174
a history of allergic reaction to cisplatin or other platinum containing compounds or doxorubicin.
Beskrivning

Allergic Reaction Cisplatin | Allergic Reaction Platinum-containing Compounds | Allergic Reaction Doxorubicin

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1527304
UMLS CUI [1,2]
C0008838
UMLS CUI [2,1]
C1527304
UMLS CUI [2,2]
C2266854
UMLS CUI [3,1]
C1527304
UMLS CUI [3,2]
C0013089
renal impairment, defined as gfr < 60 ml/min.
Beskrivning

Renal Insufficiency | Glomerular Filtration Rate

Datatyp

boolean

Alias
UMLS CUI [1]
C1565489
UMLS CUI [2]
C0017654
myocardial insufficiency, defined as nyha class > 2.
Beskrivning

myocardial; deficiency | New York Heart Association Classification

Datatyp

boolean

Alias
UMLS CUI [1]
C1401079
UMLS CUI [2]
C1275491
impaired liver function defined as bilirubin ≥ 1,5 x unl (upper normal limit).
Beskrivning

Liver Dysfunction | Serum total bilirubin measurement

Datatyp

boolean

Alias
UMLS CUI [1]
C0086565
UMLS CUI [2]
C1278039
inadequate haematological function defined as anc ≤ 1.5 x 109/l and platelets ≤ 100 x 109/l.
Beskrivning

Hematologic function Inadequate | Absolute neutrophil count | Platelet Count measurement

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0221130
UMLS CUI [1,2]
C0205412
UMLS CUI [2]
C0948762
UMLS CUI [3]
C0032181
any other condition or therapy, which in the investigator's opinion may pose a risk to the patient or interfere with the study objectives.
Beskrivning

Condition At risk Patient | Therapeutic procedure At risk Patient | Condition Interferes with Study Protocol | Therapeutic procedure Interferes with Study Protocol

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C1444641
UMLS CUI [1,3]
C0030705
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C1444641
UMLS CUI [2,3]
C0030705
UMLS CUI [3,1]
C0348080
UMLS CUI [3,2]
C0521102
UMLS CUI [3,3]
C2348563
UMLS CUI [4,1]
C0087111
UMLS CUI [4,2]
C0521102
UMLS CUI [4,3]
C2348563
previous intraabdominal chemotherapy or intraabdominal antibody therapy.
Beskrivning

Prior Chemotherapy intraabdominal | antibody therapy intraabdominal Previous

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0230168
UMLS CUI [2,1]
C0281176
UMLS CUI [2,2]
C0230168
UMLS CUI [2,3]
C0205156
Tillbaka till toppen

Similar models

Eligibility Peritoneal Carcinomatosis NCT02320448

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Carcinomatosis of peritoneal cavity
Item
clinical and radiological evidence of peritoneal carcinomatosis.
boolean
C0346990 (UMLS CUI [1])
No indication of Chemotherapy | Survival time
Item
no indication for standard chemotherapy which prolongs overall survival for at least three months.
boolean
C0521090 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C2919552 (UMLS CUI [2])
performance status | Life Expectancy
Item
performance status 0-2 and life expectancy of more than 3 months.
boolean
C1518965 (UMLS CUI [1])
C0023671 (UMLS CUI [2])
Age
Item
age > 18 years.
boolean
C0001779 (UMLS CUI [1])
Informed consent
Item
written informed consent must be obtained according to the local ethics committee requirements.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Metastatic Neoplasm Abdomen outside
Item
extraabdominal metastatic disease.
boolean
C2939420 (UMLS CUI [1,1])
C0000726 (UMLS CUI [1,2])
C0205101 (UMLS CUI [1,3])
Small bowel obstruction Symptomatic | Parenteral Nutrition, Total | Nasogastric tube
Item
symptomatic small bowel obstruction (total parenteral nutrition, nasogastric tube).
boolean
C0235329 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0030548 (UMLS CUI [2])
C0085678 (UMLS CUI [3])
Chemotherapy | Operative Surgical Procedures | Therapy, Investigational
Item
chemotherapy or surgery within the last four weeks prior to the first pipac application.
boolean
C0392920 (UMLS CUI [1])
C0543467 (UMLS CUI [2])
C0949266 (UMLS CUI [3])
Prior Therapy Cumulative Dose Maximum | Doxorubicin | Daunorubicin | Epirubicin | Idarubicin | Anthracyclines | Anthraquinones
Item
previous treatment with maximum cumulative doses of doxorubicin, daunorubicin, epirubicin, idarubicin, and/or other anthracyclines and anthracenediones.
boolean
C1514463 (UMLS CUI [1,1])
C2986497 (UMLS CUI [1,2])
C0806909 (UMLS CUI [1,3])
C0013089 (UMLS CUI [2])
C0011015 (UMLS CUI [3])
C0014582 (UMLS CUI [4])
C0020789 (UMLS CUI [5])
C0282564 (UMLS CUI [6])
C0003174 (UMLS CUI [7])
Allergic Reaction Cisplatin | Allergic Reaction Platinum-containing Compounds | Allergic Reaction Doxorubicin
Item
a history of allergic reaction to cisplatin or other platinum containing compounds or doxorubicin.
boolean
C1527304 (UMLS CUI [1,1])
C0008838 (UMLS CUI [1,2])
C1527304 (UMLS CUI [2,1])
C2266854 (UMLS CUI [2,2])
C1527304 (UMLS CUI [3,1])
C0013089 (UMLS CUI [3,2])
Renal Insufficiency | Glomerular Filtration Rate
Item
renal impairment, defined as gfr < 60 ml/min.
boolean
C1565489 (UMLS CUI [1])
C0017654 (UMLS CUI [2])
myocardial; deficiency | New York Heart Association Classification
Item
myocardial insufficiency, defined as nyha class > 2.
boolean
C1401079 (UMLS CUI [1])
C1275491 (UMLS CUI [2])
Liver Dysfunction | Serum total bilirubin measurement
Item
impaired liver function defined as bilirubin ≥ 1,5 x unl (upper normal limit).
boolean
C0086565 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
Hematologic function Inadequate | Absolute neutrophil count | Platelet Count measurement
Item
inadequate haematological function defined as anc ≤ 1.5 x 109/l and platelets ≤ 100 x 109/l.
boolean
C0221130 (UMLS CUI [1,1])
C0205412 (UMLS CUI [1,2])
C0948762 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
Condition At risk Patient | Therapeutic procedure At risk Patient | Condition Interferes with Study Protocol | Therapeutic procedure Interferes with Study Protocol
Item
any other condition or therapy, which in the investigator's opinion may pose a risk to the patient or interfere with the study objectives.
boolean
C0348080 (UMLS CUI [1,1])
C1444641 (UMLS CUI [1,2])
C0030705 (UMLS CUI [1,3])
C0087111 (UMLS CUI [2,1])
C1444641 (UMLS CUI [2,2])
C0030705 (UMLS CUI [2,3])
C0348080 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C2348563 (UMLS CUI [3,3])
C0087111 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C2348563 (UMLS CUI [4,3])
Prior Chemotherapy intraabdominal | antibody therapy intraabdominal Previous
Item
previous intraabdominal chemotherapy or intraabdominal antibody therapy.
boolean
C1514457 (UMLS CUI [1,1])
C0230168 (UMLS CUI [1,2])
C0281176 (UMLS CUI [2,1])
C0230168 (UMLS CUI [2,2])
C0205156 (UMLS CUI [2,3])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial